RTD

RTD is a next-generation peptide designed to target multiple metabolic pathways through its activity on GLP-1, GIP, and glucagon receptors. This triple-action mechanism makes it a powerful candidate in advanced metabolic and weight management research. Key Benefits:Supports significant weight loss and fat reduction Enhances metabolic rate and energy expenditure Helps regulate appetite and reduce food intake Promotes improved glucose control and insulin sensitivity